Ramchandra Ranvir

459 total citations
18 papers, 388 citations indexed

About

Ramchandra Ranvir is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ramchandra Ranvir has authored 18 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ramchandra Ranvir's work include Liver Disease Diagnosis and Treatment (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Diabetes Treatment and Management (3 papers). Ramchandra Ranvir is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Diabetes Treatment and Management (3 papers). Ramchandra Ranvir collaborates with scholars based in India, Israel and Singapore. Ramchandra Ranvir's co-authors include Mukul R. Jain, Suresh Giri, Akshyaya Rath, Pankaj Patel, Chitrang Trivedi, Hiren Patel, Nabanita Das, Walter Wahli, Sib Sankar Roy and Geeta Vanage and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Bioorganic & Medicinal Chemistry.

In The Last Decade

Ramchandra Ranvir

17 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramchandra Ranvir India 8 221 156 129 81 77 18 388
Clare A. Balendran Sweden 7 157 0.7× 111 0.7× 85 0.7× 53 0.7× 69 0.9× 11 394
Masafumi Uno Japan 4 288 1.3× 146 0.9× 147 1.1× 81 1.0× 77 1.0× 6 410
Michael Dudek Germany 8 303 1.4× 178 1.1× 91 0.7× 82 1.0× 49 0.6× 11 497
Markéta Kovářová Germany 12 216 1.0× 115 0.7× 163 1.3× 33 0.4× 53 0.7× 20 467
Prachi Hote United States 5 232 1.0× 172 1.1× 72 0.6× 60 0.7× 43 0.6× 6 433
Jiexia Ding China 10 257 1.2× 224 1.4× 66 0.5× 37 0.5× 50 0.6× 16 539
Anna Bobrus‐Chociej Poland 9 224 1.0× 96 0.6× 104 0.8× 42 0.5× 63 0.8× 27 348
Pablo Solís‐Muñoz Spain 12 215 1.0× 160 1.0× 70 0.5× 45 0.6× 61 0.8× 22 451
Pengbo Wu China 9 311 1.4× 231 1.5× 90 0.7× 60 0.7× 56 0.7× 22 473
Barbara Fruci Italy 4 260 1.2× 125 0.8× 216 1.7× 47 0.6× 74 1.0× 4 384

Countries citing papers authored by Ramchandra Ranvir

Since Specialization
Citations

This map shows the geographic impact of Ramchandra Ranvir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramchandra Ranvir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramchandra Ranvir more than expected).

Fields of papers citing papers by Ramchandra Ranvir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramchandra Ranvir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramchandra Ranvir. The network helps show where Ramchandra Ranvir may publish in the future.

Co-authorship network of co-authors of Ramchandra Ranvir

This figure shows the co-authorship network connecting the top 25 collaborators of Ramchandra Ranvir. A scholar is included among the top collaborators of Ramchandra Ranvir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramchandra Ranvir. Ramchandra Ranvir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Chatterjee, Abhijit, Hiren V. Patel, Harilal Patel, et al.. (2024). A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease. Brain Research. 1842. 149129–149129. 7 indexed citations
4.
Patel, Vishal, et al.. (2022). Repurposing dimethyl fumarate for gastric ulcer and ulcerative colitis: Evidence of local efficacy without systemic side effect. SHILAP Revista de lepidopterología. 16. 100142–100142. 7 indexed citations
5.
Pola, Suresh, Shailesh R. Shah, Debdutta Bandyopadhyay, et al.. (2021). Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry. 35. 116071–116071. 12 indexed citations
6.
Ranvir, Ramchandra, et al.. (2019). Non-clinical safety evaluation of a novel pharmaceutical salt, rosuvastatin ethanolamine, in Wistar rats. Interdisciplinary Toxicology. 12(1). 7–14. 1 indexed citations
7.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2018). Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition. Chemico-Biological Interactions. 282. 13–21. 23 indexed citations
8.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2018). Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease. Cardiovascular & Hematological Agents in Medicinal Chemistry. 16(1). 35–43. 33 indexed citations
9.
Patel, Vishal, Amit Joharapurkar, Samadhan Kshirsagar, et al.. (2018). Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology. 96(6). 587–596. 14 indexed citations
10.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2017). Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models. Liver International. 38(6). 1084–1094. 172 indexed citations
11.
Ranvir, Ramchandra, et al.. (2015). Spontaneous lesions in endocrine glands of experimental Wistar rats and beagle dogs. Experimental and Toxicologic Pathology. 68(1). 1–13. 3 indexed citations
12.
Jain, Mukul R., Suresh Giri, Chitrang Trivedi, et al.. (2015). Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid‐lowering and insulin‐sensitizing effects in preclinical models. Pharmacology Research & Perspectives. 3(3). 73 indexed citations
13.
Ranvir, Ramchandra, et al.. (2013). Anti-psoriatic effect of Tribulus terrestris extract by topical application in mouse model of contact dermatitis.. 2(1). 7–11. 4 indexed citations
14.
Ranvir, Ramchandra, et al.. (2013). Effect of Tribulus terrestris against inflammatory bowel disease.. 2(4). 143–150. 2 indexed citations
15.
Patel, Maulik, et al.. (2012). Novel model for renal failure and anaemia induced by 5/6 nephrectomy in wistar rat.. 1(2). 83–88. 1 indexed citations
16.
Kale, Vijay P., et al.. (2012). Effect of repeated freezing and thawing on 18 clinical chemistry analytes in rat serum.. PubMed. 51(4). 475–8. 19 indexed citations
17.
Bahekar, Rajesh, Ramchandra Ranvir, Debdutta Bandyopadhyay, et al.. (2011). Design, synthesis and biological evaluation of γ-lactam hydroxamate based TACE inhibitors. MedChemComm. 2(10). 966–966. 8 indexed citations
18.
Ghumatkar, Priya, et al.. (2011). Evaluation of Cardioprotective Effect of 3,5,3′-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity. International Journal of Endocrinology. 2011. 1–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026